Christobel Selecky sold $871K of IBRX stock

Christobel Selecky, Dir of ImmunityBio, Inc. (IBRX), sold 96,722 shares of IBRX stock worth $871K, per an SEC Form 4 filed Jul 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 29, 2026, 2 days before it was made public.

IBRX has moved -30.8% since the trade date, from $8.77 to $6.07 (Nov 12, 2026 close).